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Abstract
Background—Although it is clear that there are short-term effects of sodium intake on blood
pressure, little is known about the most relevant timing of sodium exposure for the onset of
hypertension. This question can only be addressed in cohorts with repeated measures of sodium
intake.
Methods—Using up to 7 measures of dietary sodium intake and blood pressure between 1991
and 2009, we compared baseline, the mean of all measures, and the most recent sodium intake in
association with incident hypertension, in 6578 adults enrolled in the China Health and Nutrition
Survey aged 18 to 65 free of hypertension at baseline. We used survival methods that account for
the interval-censored nature of this study, and inverse probability weights to generate adjusted
survival curves and time-specific cumulative risk differences; hazard ratios were also estimated.
Results—For mean and most recent measures, the probability of hypertension-free survival was
the lowest among those in the highest intake sodium group compared to all other intake groups
across the entire follow-up. In addition, the most recent sodium intake measure had a positive
dose-response association with incident hypertension [Risk Difference at 11 years of follow-up =
0.04 (95%CI −0.01, 0.09), 0.06 (0.00, 0.13), 0.18 (0.12, 0.24) and 0.20 (0.12, 0.27) for the second
to fifth sodium intake groups compared to the lowest group respectively]. Baseline sodium intake
was not associated with incident hypertension.
Conclusion—These results suggest caution when using baseline sodium intake measures with
long-term follow up.
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Evidence supporting a positive association between sodium intake and blood pressure (BP)
comes from a wide range of randomized trials, animal-based and observational studies.1
Findings suggest that BP responds relatively quickly to sodium intake; meta-analyses of
randomized trials with sodium intake reduction have shown declines in BP as early as 4 days
to 36 months.2,3 However, little is known about the most relevant associated time-frame for
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sodium exposure in relation to incident hypertension. He et al. found that the effects of an
18-month sodium reduction intervention trial had lasting effects on incident hypertension
over 7 years post-intervention, even if the individuals did not maintain a low sodium intake
after the intervention.4 Similarly, the effects on BP of a sodium reduction intervention
during the first 6 months of life lasted over 15 years later.5 These results suggest that sodium
might have a long-term influence on hypertension. However, to date, no study has compared
the effects of sodium intake across different time-frames in the same subjects. This question
can only be addressed in cohorts with repeated measures of sodium.
China provides an excellent setting for such an investigation as hypertension is increased
tremendously over the past decades6,7 and population sodium intake is high and therefore of
particular concern. In the INTERSALT Study among 45 samples worldwide, the Chinese
had the highest sodium intake.8 In 1997, the mean 24-hour urine sodium excretion in the
north of China was between 6.1 to 6.3 g.9 To date, sodium intake remains high in China,
although it decreased from about 6.6 g/d in 1991 to 4.7g/d in 2009 (possibly due to increases
in supermarkets, modern refrigeration, and modern transportation that helped decrease the
use of salt as a food preservative) (S Du, unpublished data, 2012).
We used data from the China Health and Nutrition Survey (CHNS), a large longitudinal
study that includes very detailed repeated measures of dietary sodium intake. To assess the
relation between hypertension and sodium intake from different time frames, we included all
subjects that had at least two measures of sodium intake. In the same subjects, we compared
the cumulative risk and hazard ratios (HR) for hypertension-free survival across 3 different
models: 1) sodium intake at baseline (most distal exposure), 2) the mean sodium intake




The CHNS is an ongoing study with detailed income, employment, education, demographic,
health, and nutritional information that started in 1989 with detailed follow-up across 20
years. A multistage, random cluster process was used to draw the sample in 9 provinces.
This study was approved by the institutional review committees of the University of North
Carolina at Chapel Hill and the National Institute of Nutrition and Food Safety, China
Center for Disease Control and Prevention. Participants provided their written, informed
consent. Additional details regarding the CHNS data are provided elsewhere.10
We used 1991, 1993, 1997, 2000, 2004, 2006 and 2009 exams. Eligible subjects (N =
13,764) were those that entered the cohort before 2006 and that at baseline were both 18–65
years old and free of hypertension. We excluded those that have one or fewer measurement
of BP (N=3,020), did not have at least two waves of sodium during their follow-up (before
the event or last BP measure) (N=4,107) and had missing covariates at baseline (N=59). The
final sample size was 6,578 (eFigure 1). Attrition is complex because participants missing in
one wave may come back later and new participants are recruited as replenishment samples.
Major reasons for loss to follow-up are migrant work, natural disasters, major
redevelopment of housing and relocations and refusal to participate in clinical exams.10 In
addition, for our analysis, even if subjects had complete data in many waves, some were
excluded because they developed hypertension at the earlier visits and hence, did not have at
least two waves of sodium measurement before the hypertension event. Those excluded
were younger, a higher proportion resided in urban areas, had higher education and income,
lower physical activity and entered the cohort later (eTable 1). Because the potential for
selection bias was important, we conducted two sensitivity analyses: 1) we computed
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inverse probability (IP) weights using all eligible excluded subjects that had complete data
for the covariates (N= 5581 out of a total of 7186 excluded); 2) we included all subjects with
at least one measure of sodium available (N=10,017). This analysis were not performed for
mean or recent sodium, because the majority of excluded had only baseline sodium. [eTable
3. (A, B)].
Measurement of variables
All rounds of the CHNS collected identical data from the community and household. The
data was collected by trained and certified health workers.
Dietary intake—Nutrients, including sodium, were estimated based on a combination of
three consecutive 24-hour recalls at the individual level and a food inventory at household
level performed over the same 3 day period. For the food inventory, all available foods at
the household (purchased, stored or home produced) were weighed on a daily basis, with
changes in inventory and food wastage used to estimate the total household food
consumption which was then allocated to each individual based on the three 24-hour recalls.
Condiments like salt, monosodium glutamate, and soy sauce were part of the items weighed
directly at the household level.
The sodium content was based on a Chinese food composition table in which all foods,
including processed foods, were measured with the Perkin-Elmer Analyst 800.11 However,
this food composition table, as in all other countries, does not include all processed foods
available in China. This limitation likely did not have substantial influence on our sodium
measure, because although the proportion of sodium intake coming from processed foods
has increased over time in China (1.8% in 1991 to 6.8% in 2009) processed food intake is
still relatively low (S Du, unpublished data, 2012).
A validation study was undertaken to evaluate the accuracy of estimated sodium and
potassium intake in one of the survey provinces (but not with CHNS participants). The same
methodology of dietary measurement was conducted by CHNS interviewers and 24-hour
urine samples were collected during three days (para-aminobenzoic acid was used as a
marker of completeness of 24-hour urine samples). The correlation coefficient between the
estimated dietary sodium and potassium intakes and urine sodium and potassium excretion
was 0.58 and 0.59 respectively (p = 0.005) (S Du, unpublished data, 2012). In addition, in a
previous study total energy intake was validated using doubly labeled water, this study was
conducted in Beijing (not CHNS participants) and the same methodology of dietary
measurement was conducted by interviewers trained by CHNS staff. Correlation coefficient
between the two methods was 0.56 for men and 0.60 for women,12 which is high in
comparison to other studies.
To assess which dietary variables were important for our analysis, we looked at the
correlation between sodium intake and other dietary variables that are emphasized for
hypertensive patients13 (eTable 2). We did not find large correlations, perhaps because in
China most sodium is added during cooking. Nonetheless, we include energy and potassium
intake in models, because both are validated and have well documented association with
hypertension.
Hypertension—BP was based on the mean of 3 measurements collected after a 10-min
seated rest. Standard mercury sphygmomanometers (measuring range: 0–300 mm Hg;
graduation: 2 mm Hg) with regular adult cuffs were used, the equipment was constant in all
waves. Incident hypertension was defined at the first wave that the subject reported taking
anti-hypertension medicines, and/or had high BP (≥90/140 mmHg).14
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Covariates—For physical activity we used Metabolic Equivalents per week derived from
detailed time spent and intensity levels in occupational and domestic physical activities.15
Other demographic and lifestyle covariates included gender, age, BMI, geographical region,
urban/rural residence, education level, income, smoking status and alcohol intake.
Data analysis
Because not all individuals entered the study in 1991, the year zero of follow-up was defined
at the entry point of each participant. In addition, the data is interval-censored because the
outcome was ascertained only at specific waves and we therefore did not know the exact
date of hypertension occurrence. We coded the time to event with two variables defining the
interval in which the outcome was known to have occurred (between the wave at which the
first hypertension status was found and the previous available BP measure). For example, if
an individual entered in 1993, remained free of hypertension in both 1997 and 2000 but was
classified as hypertensive in 2004, his interval was between 2000 and 2004 (or between 7
and 11 years of follow-up). If that same individual had BP measurement missing in 2000
then his interval was between 4 and 11 years of follow-up. We did not exclude subjects with
missing BP at any waves, to avoid restricting more our analytic sample. However, because
of this, many intervals for hypertension onset were considerably wide; therefore we
conducted a sensitivity analysis excluding subjects with interim missing BP data points
[eTable 3. (C)].
As our main effect measure, we present time-specific differences in the cumulative
probability of hypertension-free survival. We used Turnbull’s approach16 to estimate the
nonparametric maximum likelihood estimates of the cumulative probability via the SAS 9.2
procedure LIFEREG (SAS Institute Inc., Cary, NC). To account for confounding, we used
IP weights. We fitted a multinomial logistic regressions to estimate the probability of
exposure, Pr(X=x), as well as the probability of exposure conditional on the confounders,
Pr(X=x | Z). We calculated stabilized IP weights as Pr(X=x)/Pr(X=x | Z)17 for each exposure
(sodium at baseline, mean and recent), and incorporated these to estimate the adjusted
survival curves (Figure 1) and adjusted cumulative risks (Table 2). We used a nonparametric
bootstrap approach to estimate the standard error of the risk difference. Specifically, we
drew 200 simple random samples, each of size 6578, with replacement; we then estimated
the IP weights and calculated the risk difference in each of the 200 samples; finally we took
the standard deviation of the 200 estimates as the estimate of the standard error for the risk
difference. We note that, with interval censored data, Turnbull’s estimator is not regular
asymptotically linear, so the standard theoretical justification for the bootstrap does not hold.
However, the bootstrap performed well in both simulations and prior examples.18,19
As an alternative, we also present the more familiar regression-adjusted HRs, these were
estimated using flexible parametric models for survival-time data [stpm in STATA 12.1
(StataCorp, College Station, TX)], because this procedure can handle interval-censored data.
This method runs spline-smoothed versions of log-logistic or proportional hazards Weibull
models. As previously suggested,20 we selected the log-logistic and 4 spline knots based on
the lowest Akaike Information Criterion.
Exposure periods—The main exposure was sodium intake from three different exposure
periods. 1) Baseline sodium was the first available measure of sodium; in 8% of the sample
sodium at baseline (year 0 of follow-up) was missing, so we use the next available sodium
intake measure. 2) Mean sodium was the arithmetic mean of all available sodium
measurements during follow-up (i.e. mean of sodium available from year 0 to 6 of follow-
up, if year 9 was the last BP measure). 3) Recent sodium was the last measure of sodium (i.e.
sodium at year 6 of follow-up, if year 9 was the last BP measure). Because our aim was to
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compare different time frames of sodium intake in the same sample, we restricted our
analysis to individuals with at least two measures of sodium before the event or censoring.
For each exposure period we ran a separate model. Baseline sodium was categorized in
quintiles, and mean and recent sodium were categorized in five groups using the cutoff
values of the quintiles at baseline; this was done to maintain comparability across models.
Therefore in this manuscript we refer to “quintiles” when is specific to baseline intake and to
“groups” if otherwise. Lastly, we evaluated the effect of different combinations of baseline
and recent sodium exposures. We ran a model including baseline and recent sodium
simultaneously and computed the HR and 95% confidence intervals for several linear
combinations of the coefficients.
Confounders—We selected potential confounders based on known factors associated with
hypertension, and on the association of covariates with sodium intake and the outcome in
our data. We controlled for covariates at baseline including age, BMI, gender, geographical
region, urban/rural residence, education level, income, physical activity, smoking, alcohol
intake and wave of entry. Energy and potassium intake were defined at baseline, mean of
follow-up, or recent according to each type of sodium assessed.
RESULTS
The median follow-up was 11 years (range: 5–18), the average number of sodium
measurements per individual was 3.3 (range: 2–6). The mean time between the recent
sodium measurement and the event or censoring was 3.5 years (range: 2–16). This last wide
range was due to the inclusion of subjects with missing BP at waves of data collection. In
our third sensitivity analysis, in which we found similar results, this range was 2 to 4 years
[eTable 3. (C)].
Sodium intake at baseline and the incidence of hypertension tended to be higher in males,
central geographic region or rural residence, lower education level, higher energy intake,
higher physical activity, smokers and in subjects entering the cohort in 1991. In addition,
incidence of hypertension was higher in those with lower income, older age and higher BMI.
Sodium was slightly higher in younger subjects and in individuals who had higher alcohol
intake (Table 1).
The sodium intake across the three different temporal exposure measures was higher in
individuals with incident hypertension (Table 1). According to the adjusted hypertension-
free survival probability curves for mean and recent sodium exposures, the 5th group
(highest intake) had the lowest survival (Figures 1B and 1C). However for mean sodium
intake the survival probability of the 3rd group was slightly higher than that of the 1st group
(lowest sodium intake). In the case of baseline sodium (Figure 1A), all quintiles were closer
to each other in survival. In Table 2, we present the cumulative risk and cumulative risk
difference at the median time of follow-up (11 years). For the baseline sodium measure the
cumulative risk was around 20% for all sodium intake groups. But for mean and recent
sodium measures the highest sodium intake groups had a cumulative risk of hypertension of
30% and the third group had a cumulative risk of 17%, the key difference between the mean
and the recent was that the lowest group had 26% and 11% respectively. The HRs presented
in Table 3, in this study, have a similar interpretation. Adjusting for all measured covariates
did not meaningfully affect the results.
Finally, we assessed the effect of change in sodium intake from baseline to recent period
(Table 4). The predicted hazard was higher among individuals who remained in the 5th
(high) intake group at baseline and at the most recent exam, compared with individuals who
remained in the 1st (low) intake group at both points [HR=1.98 (95% CI= 1.47, 2.67)].
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However, the estimated effect was slightly stronger when comparing subjects who increased
from low to high sodium intake, with subjects that decreased from high to low [2.27 (1.64,
3.14)]. The estimate that compared high vs. low intake at the recent sodium controlling for
baseline intake was 2.12 (1.69, 2.67), this estimate was similar to that shown in Table 3,
where no adjustment by baseline sodium was done [2.10 (1.67, 2.63)].
DISCUSSION
In this longitudinal study we found that the baseline measure of sodium intake had no
association with increased risk of incident hypertension in a median follow-up of 11 years.
These results are comparable to other studies that only studied sodium intake at baseline. In
a Taiwanese study with a median follow-up period of 7.9 years, there was a weak J-shape
relationship of sodium intake at baseline with incident hypertension.21 In a European study
with a median follow-up of 6.5 years, the risk of incident hypertension did not increase
across tertiles of urinary sodium measured at baseline.22
In models using only a baseline sodium exposure, the assumption is that either sodium
intake remains constant over time and the whole follow-up period is the relevant time frame,
or that the specific point in time (baseline measurement) and not the entire follow-up period
is associated with disease incidence. Therefore, even if there were subsequent changes in
diet, baseline exposure could be associated with the outcome. Some studies rely on this
latter reasoning. For example, a low-sodium intervention during infancy (first 6 months of
life) had effects on BP 15-years later even when the estimated sodium intake at follow-up
was no longer different among intervention groups.6 Similarly, 7 years following the Trials
of Hypertension Prevention, Phase 1, the sodium intake was no longer different between the
groups, but those who were in the sodium reduction intervention group had a 35 percent
reduced odds (OR= 0.65, 95%CI= 0.25, 1.69) of incident hypertension.4 These studies
suggest that even when one measure of sodium does not represent long-term exposure, it
still can have long-term effects on hypertension. In our study, this was not the case; a
possible explanation is that the effects of an intervention, in which sodium intake is
dramatically and intentionally reduced for a period of time, is different than the effect of a
typical intake at a specific point long time ago.
If diet changes over time and the hypothesis is that relevant time-frame is the entire follow-
up period, a better way to test this is to collect repeated measures of the exposure and
examine their average over time. This measure however, could reduce measurement error
due to intra-individual variation and therefore result in a stronger association.23
Surprisingly, in our analysis even if the mean measure had a lower degree of error, the mean
sodium intake measure did not have a stronger association compared to recent intake.
In our final analysis, we compared different combinations of baseline and recent intake. The
strongest estimate of those studied was found when comparing low-baseline, high-recent vs.
high-baseline, low-recent; suggesting that there might be a deleterious effect related to
increasing sodium intake (from baseline to recent), and a beneficial effect of decreasing it,
however all these estimates were imprecise as demonstrated by wide 95% CIs.
It is important to acknowledge that we observed high variability in our estimate of sodium
intake over time. As shown in Table 1, lower and higher sodium values at baseline were
followed in the recent period by values closer to the mean; this regression to the mean is
expected when measurements have random error.24 A key source of random error might be
related to the day-to-day variability not captured by our dietary measure, which is based on
3-days of intake only. However, because sodium is not an episodically consumed nutrient,
day-today variability might be less important compared to other micronutrients/foods.
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Indeed, most sodium literature is based on 24-hr urine which is a short-term measure that
also misses day-today variability; still, consistent associations between sodium intake and
blood pressure and cardiovascular diseases have been reported in the literature.2,25
Furthermore, most sodium in China is added during cooking (with high household-to-
household variability), so the fact that we include household weighing in our methodology
strengthens our measure, long-term instruments, such as food frequency questionnaires, that
do not include weighing of foods and condiments will hardly capture sodium intake. Still,
we cannot know how much of the variability over time in our measure, is due random error
and how much is due to true changes in diet. Nevertheless, random error generally
attenuates the strength of association,26 so even if our estimates are attenuated we were still
able to address our research question regarding the comparison of associations between
sodium intake and incident hypertension across varying time frames.
A strength of our analysis is the use of IP weights that allowed us to estimate cumulative
risk difference as an effect measure and to present adjusted survival curves that retain a
marginal interpretation.17 HRs can be misleading because of their non-collapsibility27 and
because a single HR averaged over the duration of the follow-up might be inadequate if the
HR changes over time.28 The adjusted survival curves, serve to overcome these problems
and have the additional advantage of providing absolute risks, which can have a more direct
interpretation.
Another strength was the use of models that account for interval-censored data.20,29 This
type of data is quite usual in prospective studies in which participants are evaluated at
certain times and not continuously. Assuming that the event occurred at the end or mid-point
of each interval, and apply standard survival methods, has been shown to produce biased
estimates.30 Discrete-time hazard models could have been an alternative if our interval
lengths were equal or did not overlap, but that was not the case in our data set. However, an
important limitation of models that account for interval-censored data is that they cannot
incorporate time-varying variables. This is a limitation particularly for the mean and recent
sodium measures; because although these exposures happened at different years of follow-
up (i.e. for one person recent sodium happened in year 6, for another it happened in year 13),
these variables were time-fixed and had the same value during the entire follow-up. This
could have introduced bias in our results, because when the probability of event was
estimated in the interval 7 to 9 years, for example, the sodium groups compared included
information not only for sodium consumed until year 7, but they included information from
sodium consumed after because it included the recent or mean intake of those that remained
in the study free of hypertension longer. As a sensitivity analysis we used only the first two
sodium measures, which everyone had, this way the mean and recent sodium was from
around the same years of follow-up for everyone. As could be expected, the mean sodium
(mean of the first two measures) and the recent sodium (second measure) had a weaker
association to incident hypertension, but consistent with our main results, their association
was stronger compared to the baseline sodium [eTable 3. (D)].
Limitations of this study also include that although our definition of hypertension is what is
commonly used in population studies21,25,31 the ideal clinical definition of hypertension
often is based on the average of 2 or more BP readings on each of 2 or more office visits.14
Here, we had 3 measures, but they were taken in the same day. Sample selectivity is another
key issue, our sample dropped from 13,764 eligible subjects to 6,578 with sample
exclusions. Selection bias arises when, by analyzing only those included in the sample, we
condition on common effects of the exposure and the outcome32. In our data it seemed that
sodium intake at baseline was not related to being selected for the analytic sample (Table 1.
Electronic Appendix), therefore selection bias was less likely to be present. In addition, the
results of two different sensitivity analyses also suggested that our main analysis had
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minimal bias of this kind. However, we do not have any information of the mean and recent
sodium intake among those excluded from our analysis. Although we do not have a reason
to believe these would be any different than baseline sodium, we cannot evaluate to which
extent the sodium-hypertension relationship was different among those excluded,
particularly for mean and recent sodium.
In conclusion, we found that in this population prospective repeated measures of the
exposure were fundamental to adequately study the sodium-hypertension relation. The fact
that we observed a null association between baseline sodium intake and hypertension,
suggests that baseline measures from a long-term follow up may not be the salient time
frame for hypertension exposure.
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Non-parametric Adjusted Survival Probability Curves for Incident Hypertension by Baseline
Sodium Intake (A), Mean Sodium Intake (B) and Recent Sodium Intake (C) for sodium
groups 1 (lowest intake), 3 and 5 (highest intake).
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TABLE 3
Hazard Ratios for Incident Hypertension Comparing to the Lowest Intake Group.
Baseline sodium intake Mean sodium intake Recent sodium intake
HR (95% CI) HR (95% CI) HR (95% CI)
 Crude estimate
G1 ( <3.7 g/d)a 1 1 1
G2 ( 3.7–5.2 g/d) 0.83 (0.67, 1.01) 0.75 (0.58, 0.95) 1.21 (1.01, 1.44)
G3 (5.2–6.6 g/d) 0.70 (0.57, 0.86) 0.79 (0.62, 1.01) 1.29 (1.06, 1.57)
G4 (6.6–8.7 g/d) 0.77 (0.63, 0.94) 0.99 (0.78, 1.27) 1.89 (1.53, 2.34)
G5 ( >8.7 g/d) 0.90 (0.74, 1.10) 1.47 (1.10, 1.95) 1.90 (1.53, 2.36)
 Adjustedb
G1 ( <3.7 g/d)a 1 1 1
G2 ( 3.7–5.2 g/d) 0.83 (0.67, 1.02) 0.79 (0.61, 1.01) 1.27 (1.05, 1.52)
G3 (5.2–6.6 g/d) 0.72 (0.58, 0.89) 0.90 (0.70, 1.16) 1.47 (1.20, 1.80)
G4 (6.6–8.7 g/d) 0.77 (0.62, 0.95) 1.17 (0.90, 1.52) 2.03 (1.63, 2.52)




Adjusted by covariates at baseline: age, BMI, gender, region, urban/rural, education level, income, physical activity, smoking, alcohol intake and
wave of entry. Energy and potassium intake were included in the model as baseline, mean or recent accordingly.
CI, confidence interval; G, group; HR, Hazard Ratio.
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TABLE 4
Hazard Ratiosa for Incident Hypertension Comparing Different Combinationsb of High (>8.7 g/d) and Low
(<3.7 g/d) Sodium Intake at Baseline and at the Most Recent Exam
HR (95% CI)
High-baseline, High-recent vs. Low-baseline, Low-recent 1.99 (1.48, 2.68)
Low-baseline, High-recent vs. High-baseline, Low-recent 2.42 (1.74, 3.35)
High-recent vs. Low-recent; baseline held constant 2.19 (1.74, 2.76)
High-baseline vs. Low-baseline; recent held constant 0.91 (0.73, 1.12)
a
Estimates are linear combinations of coefficients from a model with baseline and recent sodium intake groups and covariates at baseline: age,
BMI, gender region, urban/rural, education level, income, physical activity, smoking, alcohol intake, wave of entry; and energy and potassium
intake at baseline and recent period. No interaction term was added (p-value=0.64 of Likelihood Ratio Test comparing model with and without
baseline by recent interaction term).
b
Number of subjects in each combination: High-baseline, High-recent (N=215); Low-baseline, Low-recent (N=436); Low-baseline, High-recent
(N=98); High-baseline, Low-recent (N=312); High-recent (N=765); Low-recent (N=1831); High-baseline (N=1316); Low-baseline (N=1315).
CI, confidence interval; HR, Hazard Ratio.
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